María Jesús Pascual-Cascón

Posttransplant cyclophosphamide vs cyclosporin A and methotrexate as GVHD prophylaxis in matched sibling transplantation

Mi Kwon, Rebeca Bailén, María Jesús Pascual-Cascón et al. · Blood Advances · 2019 · 44 citations · Full text

Gvhd Prophylaxis, Immunology, Immunotherapy +16

Mesenchymal Stromal Cells for Treating Steroid-Resistant Acute and Chronic Graft Versus Host Disease: A Multicenter Compassionate Use Experience

María del Mar Macías-Sánchez, Cynthia Morata‐Tarifa, Natividad Cuende et al. · Stem Cells Translational Medicine · 2022 · 22 citations · Full text

Cell Therapy, Immunology, Transplantation Medicine +24

Association of Serum Ferritin Levels Before Start of Conditioning With Mortality After alloSCT – A Prospective, Non-interventional Study of the EBMT Transplant Complications Working Party

Olaf Penack, Christophe Peczynski, Steffie van der Werf et al. · Frontiers in Immunology · 2020 · 20 citations · Full text

Post-Transplantation Cyclophosphamide After HLA Identical Compared to Haploidentical Donor Transplant in Acute Myeloid Leukemia: A Study on Behalf of GETH-TC

Rebeca Bailén, María Jesús Pascual-Cascón, Manuel Guerreiro et al. · Transplantation and Cellular Therapy · 2022 · 18 citations · Full text

Association of uric acid levels before start of conditioning with mortality after allogeneic hematopoietic stem cell transplantation – a prospective, non-interventional study of the EBMT Transplant Complication Working Party

Olaf Penack, Christophe Peczynski, Steffie van der Werf et al. · Haematologica · 2019 · 11 citations · Full text